Status:
TERMINATED
Renal Denervation for Complicated Hypertension
Lead Sponsor:
Baker Heart and Diabetes Institute
Conditions:
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
This is an observational proof of concept study investigating the safety and effectiveness of renal denervation to lower blood pressure in people whose blood pressure is not adequately controlled due ...
Eligibility Criteria
Inclusion
- BP ≥140/90 mmHg (or ≥130/80 mmHg for patients with diabetes)
- Intolerance to ≥2 antihypertensive drug classes
- Inability to take Angiotensin-Converting-Enzyme Inhibitor (ACEI), Angiotensin II Receptor Blockers (ARBs) or Direct Renin inhibitors (DRIs) due to planned pregnancy
- Renal artery stenosis
- Chronic Kidney Disease
Exclusion
- renal artery anatomy ineligible for treatment
- individual has had myocardial infarction, unstable angina or cerebrovascular accident within 6 months of screening visit
- female participants of childbearing potential must have negative pregnancy test prior to treatment
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01865253
Start Date
May 1 2012
End Date
March 1 2015
Last Update
November 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baker IDI Heart & Diabetes Institute
Melbourne, Victoria, Australia, 3004